{"url":"https://lda.senate.gov/api/v1/filings/2c50c63a-1d60-482a-b45f-54881d2fbb13/","filing_uuid":"2c50c63a-1d60-482a-b45f-54881d2fbb13","filing_type":"2T","filing_type_display":"2nd Quarter - Termination","filing_year":2016,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2c50c63a-1d60-482a-b45f-54881d2fbb13/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chris Jones","dt_posted":"2016-07-19T12:17:43.840000-04:00","termination_date":"2016-05-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Ave NW","registrant_address_2":"Suite 230","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400446141,"url":"https://lda.senate.gov/api/v1/registrants/400446141/","house_registrant_id":null,"name":"FERGUSON STRATEGIES, LLC","description":"Government affairs and public policy consulting firm.","address_1":"801 Pennsylvania Ave NW","address_2":"Suite 230","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004-2697","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS JONES","contact_telephone":"+1 202-861-1617","dt_updated":"2022-04-06T16:07:13.725346-04:00"},"client":{"id":190989,"url":"https://lda.senate.gov/api/v1/clients/190989/","client_id":87,"name":"GENENTECH, INC.","general_description":"Biotechnology research and manufacturer.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-09-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Policy and implementation issues relating to Public Law No. 111-148, the \"Patient Protection and Affordable Care Act.\"\nPolicy and implementation issues relating to Public Law No. 112-144, the \"Food and Drug Administration Safety and Innovation Act,\" specifically those sections relating to the Prescription Drug User Fee program.\nH.R. 6, the \"21st Century Cures Act.\"","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":47998,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"JONES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51135,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"HIGGINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}